Data on Chemicals and Chemistry Reported by Researchers at Mississippi State University.

Researchers at Mississippi State University have conducted a study on the immunosuppressive effects of cannabinoids in multiple sclerosis (MS). The study used an in vitro model to mimic T cell activation in MS and found that cannabidiol (CBD) and A9-tetrahydrocannabinol (THC) suppressed cytokine production. The researchers concluded that this in vitro model can be used to evaluate the immune effects of cannabinoid compounds. The study was supported by the National Institutes of Health (NIH) and has been peer-reviewed. [Extracted from the article]

Copyright of Cannabis & Marijuana News is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)